Turing is proud to be an official launch partner for Anthropic’s Claude for Life Sciences—Claude enhanced for industry use-cases, including access to key MCPs and tailored agentic capabilities.
This partnership combines Anthropic’s cutting-edge model development and safety-first architecture with Turing’s proven track record building enterprise-grade AI systems. For Life Sciences leaders, that means access to AI that’s not only powerful, but also compliant, explainable, and ready for regulated environments.
Claude for Life Sciences is enhanced for industry use-cases like accelerating research workflows with AI that understands your experiments, integrates with your lab systems, and delivers publication-quality insights from hypothesis to discovery.
This launch marks a pivotal moment in the evolution of industry-specific foundation models, offering advanced intelligence paired with tailored capabilities that support real-world impact across the Life Sciences value chain.
Life Sciences companies face unique challenges in compliance, precision, and risk. Claude addresses these with:
Claude for Life Sciences helps operationalize AI within regulated environments. By aligning advanced AI with the workflows, safeguards, and scientific rigor Life Sciences demands, Claude helps teams accelerate discovery, reduce risk, and scale impact with confidence.
Turing’s selection as a launch partner for Claude for Life Sciences reflects our deep expertise, enterprise credibility, and, most notably, proven track record in strategic AI implementation. As Anthropic explains, this partnership is about more than model access—it’s about bringing safe, scalable intelligence to one of the most demanding industries in the world:
“Life Sciences organizations face some of the highest bars for accuracy, traceability, and trust in AI. Working with partners like Turing, we’re helping the industry move from experimentation to execution with systems that are as reliable as they are innovative.”
Turing Intelligence applies AI to enterprise workflows, and fast. With proprietary intelligence, we deploy AI models and agents from frontier labs but fine-tune them on our own proprietary data, knowledge and workflows. The result? Faster, more accurate decisions, improved precision and compliance, and measurable ROI.
As a launch partner, Turing contributes:
"Partnering with Anthropic on Claude for Life Sciences brings together their frontier model innovation with the applied AI systems expertise we’ve built through Turing Intelligence," said James Raybould, SVP and GM of Turing Intelligence. “From audit readiness to protocol optimization, we're enabling teams to apply AI where it actually matters without compromising on safety or control."
Claude’s capabilities + Turing’s execution model = faster time-to-value.
The future of AI in Life Sciences won’t be defined by model power alone, but by the proprietary intelligence driven by real-life science data and leveraged by tools like Claude for Life Sciences. Turing is proud to help lead this next chapter alongside Anthropic, shaping a more precise, compliant, and impactful future.
If you’re looking to drive measurable ROI with AI, talk to a Turing Strategist and see how Claude for Life Sciences can make this a reality for your enterprise.
Turing provides human-generated, proprietary datasets and world-class tuning support to get your LLM enterprise-ready.